Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial
article
OA: closed
CC0
⤵ 47 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This prospective, randomized, placebo-controlled, double-blind trial investigated the efficacy of gonadotropin-releasing hormone agonist combined with hormone replacement therapy compared to placebo for endometriosis treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
- Deficient cellular immunity in endometriosis via openalex
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis via openalex
- GnRH agonists and add‐back therapy: is there a perfect combination? via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- W1968557684 via openalex
- W2115941653 via openalex
- W2009881284 via openalex
- W164119867 via openalex
- W83559662 via openalex
- W201040832 via openalex
Cited by (48)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Medical treatments of endometriosis: a review 2022
- Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids 2022
- Pharmacological Management of Endometriosis-related Pain: The Expert Opinion 2021
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Use of dienogest in endometriosis: a narrative literature review and expert commentary 2020
- Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis 2020
- Laparoscopic Surgery in Adolescent Endometriosis 2020
- Postoperative Hormonal Suppression for Prevention of Deeply Infiltrative Endometriosis Recurrence After Surgery 2018
- Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture 2018
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy 2017
- Gonadotropin-releasing hormone agonist with add–back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis 2016
- Effects of different add-back regimens on hypoestrogenic problems by postoperative gonadotropin-releasing hormone agonist treatment in endometriosis 2016
- Analogs of Luteinizing Hormone-Releasing Hormone in the Treatment of Endometriosis 2015
- Safety of medical treatments for endometriosis 2015
- Emerging therapy for endometriosis 2015
- Comparison of complete and incomplete excision of deep infiltrating endometriosis. 2015
- Minimising menopausal side effects whilst treating endometriosis and fibroids 2015
- Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis 2014
- Effectiveness of Conservative Surgery and Adjunctive Hormone Suppression Therapy versus Surgery Alone in the Treatment of Symptomatic Endometriosis: A Systematic Review with Meta-analysis 2013
- Integrated Pharmacometrics and Systems Pharmacology Model‐Based Analyses to Guide GnRH Receptor Modulator Development for Management of Endometriosis 2012
- Management of Endometriosis-Related Pain: An Update 2011
- [Endometriosis: necessary and sequential therapeutic procedures and guidelines]. 2011
- Endometriosis: Necessary and Sequential Therapeutic Procedures and Guidelines 2010
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Current pharmacotherapy for endometriosis 2010
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? 2010
- Immediate and delayed add‐back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain 2009
- Emerging drugs in endometriosis 2006
- The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age 2006
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Pain Associated with Endometriosis: Therapeutic Options 2006
- Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
- Medical treatment options for endometriosis 2006
- Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy 2005
- Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy 2005
- Add-back therapy in the treatment of endometriosis-associated pain 2004
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial 2004
- Medikamentöse und konservative Therapie 2004
- Rezidivierende Endometriose?ein Kofaktor der vorzeitigen Menopause? 2003
- Luteinizing Hormone-releasing Hormone Antagonists in Gynecology 2003
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density 2003
- Will GnRH antagonists assist in the treatment of benign gynaecological diseases? 2002
- Medikamentöse Therapie der Endometriose mit GnRH-Antagonisten 2002
- Use of GnRH antagonists in the treatment of endometriosis 2002
- Ovarian endometriosis and peritoneal endometriosis: are they different entities from a fertility perspective? 2002
- Endometriosis: current concepts and therapy 2002
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:36.046895+00:00
License: CC0
· commercial use OK